Literature DB >> 25753593

Diffuse optical tomography of breast carcinoma: can tumor total hemoglobin concentration be considered as a new promising prognostic parameter of breast carcinoma?

Mengsu Xiao1, Yuxin Jiang2, Qingli Zhu1, Shanshan You1, Jianchu Li1, Hongyan Wang1, Xingjian Lai1, Jing Zhang3, He Liu1, Jing Zhang3.   

Abstract

RATIONALE AND
OBJECTIVES: Diffuse optical tomography (DOT) is an emerging functional modality, which can reflect tumor metabolic activity and angiogenesis. The purpose of this exploratory study was to correlate the total hemoglobin concentration (THC) measured by noninvasive DOT with prognostic factors in breast carcinomas.
MATERIALS AND METHODS: We prospectively imaged 251 breast carcinomas in 229 consecutive women (mean age, 51.18 ± 12.32 years) using DOT from 2007 to 2010. Tumor angiogenesis and metabolic activity were assessed based on quantitatively measured THC. The THC was correlated with prognostic factors, including tumor size, histopathologic classification, histologic grade, estrogen receptor (ER), progesterone receptor (PR), c-erbB-2, and p53.
RESULTS: In univariate analysis, THC was significantly correlated with the following prognostic factors: tumor size (P < .001), histologic grade (P < .001), ER (P < .05), PR (P < .001), and c-erbB-2 (P < .05). THC was not associated with histopathologic classification (P = .170) or p53 (P = .463). On the basis of a stepwise multiple regression analysis, THC of invasive ductal carcinoma was significantly correlated with tumor size (P < .001), histologic grade (P < .001), and PR (P < .05).
CONCLUSIONS: THC was associated with prognostic factors of breast carcinoma. THC may be considered as a new prognostic parameter of breast carcinoma and a prediction of tumor behavior and biological activity.
Copyright © 2015 AUR. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Breast carcinoma; angiogenesis; diffuse optical tomography; prognostic factors; total hemoglobin concentration

Mesh:

Substances:

Year:  2015        PMID: 25753593     DOI: 10.1016/j.acra.2014.12.012

Source DB:  PubMed          Journal:  Acad Radiol        ISSN: 1076-6332            Impact factor:   3.173


  3 in total

1.  Diffuse optical tomography changes correlate with residual cancer burden after neoadjuvant chemotherapy in breast cancer patients.

Authors:  Emerson A Lim; Jacqueline E Gunther; Hyun K Kim; Molly Flexman; Hanina Hibshoosh; Katherine Crew; Bret Taback; Jessica Campbell; Kevin Kalinsky; Andreas Hielscher; Dawn L Hershman
Journal:  Breast Cancer Res Treat       Date:  2017-02-11       Impact factor: 4.624

2.  US-localized diffuse optical tomography in breast cancer: comparison with pharmacokinetic parameters of DCE-MRI and with pathologic biomarkers.

Authors:  Min Jung Kim; Min-Ying Su; Hon J Yu; Jeon-Hor Chen; Eun-Kyung Kim; Hee Jung Moon; Ji Soo Choi
Journal:  BMC Cancer       Date:  2016-02-01       Impact factor: 4.430

3.  US-guided Diffuse Optical Tomography: Clinicopathological Features Affect Total Hemoglobin Concentration in Breast Cancer.

Authors:  Wenxiang Zhi; Yu Wang; Cai Chang; Fen Wang; Yaling Chen; Na Hu; Xiaoli Zhu; Li Xie
Journal:  Transl Oncol       Date:  2018-05-09       Impact factor: 4.243

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.